Biosimilar regulation and approval in Jordan

Abstract:
The regulatory oversight of medicinal products in Jordan is achieved by the Jordan Food and Drug Administration (JFDA). Since 2015, the JFDA put guidelines in place for the regulation and approval of biosimilar products., that are similar to those developed in Europe This paper outlines the current requirements for approval and use of biosimilars laid out by the JFDA.

Subscribe now to GaBI Journal to view full information of this article to be published in the next journal issue.

Source URL: http://gabi-journal.net/biosimilar-regulation-and-approval-in-jordan.html


Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048